The second group is hypothesized to be related to biallelic MSH2 somatic mutations.51 Endometrial cancer patients with sporadic mutations in MMR proteins typically present at a more advanced stage, with larger, higher grade tumors, and more lymph nodes involvement. Here, MSH2 is linked to endometrial cancer.